Wooree BioLtd (A082850) Stock Overview
Engages in the production and sale of flexible circuit boards in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
A082850 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Wooree Bio Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,105.00 |
| 52 Week High | ₩3,650.00 |
| 52 Week Low | ₩1,995.00 |
| Beta | 0.96 |
| 1 Month Change | -8.08% |
| 3 Month Change | -12.11% |
| 1 Year Change | -21.89% |
| 3 Year Change | -38.09% |
| 5 Year Change | -62.68% |
| Change since IPO | -71.26% |
Recent News & Updates
Wooree BioLtd (KOSDAQ:082850) Could Be Struggling To Allocate Capital
May 16
Why Wooree BioLtd's (KOSDAQ:082850) Shaky Earnings Are Just The Beginning Of Its Problems
Mar 28Recent updates
Wooree BioLtd (KOSDAQ:082850) Could Be Struggling To Allocate Capital
May 16Why Wooree BioLtd's (KOSDAQ:082850) Shaky Earnings Are Just The Beginning Of Its Problems
Mar 28Does Wooree BioLtd (KOSDAQ:082850) Have A Healthy Balance Sheet?
Dec 16Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%
Oct 23Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%
Sep 07Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns
Aug 30Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?
Aug 10Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up
Jul 19Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising
May 25These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well
May 03Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too
Apr 26Should You Invest In Wooree BioLtd (KOSDAQ:082850)?
Feb 28Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly
Feb 01
Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 12Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain
Dec 21Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative
Nov 29Shareholder Returns
| A082850 | KR Semiconductor | KR Market | |
|---|---|---|---|
| 7D | 4.0% | -3.1% | 1.6% |
| 1Y | -21.9% | 164.6% | 61.8% |
Return vs Industry: A082850 underperformed the KR Semiconductor industry which returned 195% over the past year.
Return vs Market: A082850 underperformed the KR Market which returned 68% over the past year.
Price Volatility
| A082850 volatility | |
|---|---|
| A082850 Average Weekly Movement | 4.1% |
| Semiconductor Industry Average Movement | 7.2% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 10.8% |
| 10% least volatile stocks in KR Market | 2.5% |
Stable Share Price: A082850 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A082850's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 89 | Gil-Soo Park | www.wooreebio.co.kr |
Wooree Bio Co.,Ltd, together with its subsidiaries, engages in the production and sale of flexible circuit boards in South Korea. The company also offers LED packages and modules; separators for secondary batteries; backlight components for thin film transistor-liquid crystal displays; and sells and assembles TVs. It also provides natural health functional food products; cosmetics; and pharmaceutical ingredient business based on plant factories.
Wooree Bio Co.,Ltd Fundamentals Summary
| A082850 fundamental statistics | |
|---|---|
| Market cap | ₩99.37b |
| Earnings (TTM) | -₩12.93b |
| Revenue (TTM) | ₩1.17t |
Is A082850 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A082850 income statement (TTM) | |
|---|---|
| Revenue | ₩1.17t |
| Cost of Revenue | ₩1.06t |
| Gross Profit | ₩104.84b |
| Other Expenses | ₩117.76b |
| Earnings | -₩12.93b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -273.79 |
| Gross Margin | 8.98% |
| Net Profit Margin | -1.11% |
| Debt/Equity Ratio | 40.8% |
How did A082850 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/14 07:10 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Wooree Bio Co.,Ltd is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jonathan Rhee | Citigroup Inc |
| Sang Hyeon Park | iM Securities |
| Jong Woo Yoo | Korea Investment & Securities Co., Ltd. |